Shocking the brain back to speech: new hope for stroke survivors
NCT ID NCT03651700
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether combining transcranial magnetic stimulation (TMS) with language therapy helps people with chronic aphasia—a language disorder after stroke—speak better. 86 participants received either real TMS or a sham version, plus language therapy, over two weeks. The main goal was to see if language scores improved six months later.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Transcranial magnetic stimulation (TMS) and constraint-induced language therapy (CILT)
What this could lead to
If it works, this could point toward a non-invasive treatment to improve language recovery in people with long-term aphasia after stroke.
What could go wrong
This is a phase 2 trial with only 86 participants, so results may not apply to everyone. The treatment is short-term and effects may fade over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for APHASIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States